Oral inactivated non-typeable Haemophilus influenzae vaccine for prevention of acute bronchitis episodes in mild to moderate airway disease

Phase 2, randomised trial in acute bronchitis and airway diseases comparing HI-1-164-AS oral tablets with Placebo tablets (2 arms). Primary endpoints: Number of episodes of acute bronchitis during the study, Proportion of subjects experiencing an episode of acute bronchitis during the study and 2 more. Started Mar 2006; status: completed.